Tirzepatide is a medication primarily used for the treatment of type 2 diabetes and obesity. It’s a dual GIP (Gastric Inhibitory Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptor agonist. By targeting both of these hormones, tirzepatide helps regulate blood sugar levels, promote insulin secretion, and reduce appetite, leading to weight loss. It’s sold under the brand name Mounjaro. Tirzepatide has gained …